IL143994A0 - Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells - Google Patents

Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Info

Publication number
IL143994A0
IL143994A0 IL14399499A IL14399499A IL143994A0 IL 143994 A0 IL143994 A0 IL 143994A0 IL 14399499 A IL14399499 A IL 14399499A IL 14399499 A IL14399499 A IL 14399499A IL 143994 A0 IL143994 A0 IL 143994A0
Authority
IL
Israel
Prior art keywords
growth hormone
human growth
stem cells
hematopoietic stem
pluripotent hematopoietic
Prior art date
Application number
IL14399499A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL143994A0 publication Critical patent/IL143994A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14399499A 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells IL143994A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
IL143994A0 true IL143994A0 (en) 2002-04-21

Family

ID=8233268

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14399499A IL143994A0 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
IL143994A IL143994A (en) 1998-12-30 2001-06-26 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143994A IL143994A (en) 1998-12-30 2001-06-26 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Country Status (15)

Country Link
US (1) US20060029581A1 (https=)
EP (3) EP1016413A1 (https=)
JP (1) JP4808316B2 (https=)
AT (1) ATE342064T1 (https=)
AU (2) AU772222B2 (https=)
BR (1) BR9916726A (https=)
CA (1) CA2354194A1 (https=)
CY (1) CY1107603T1 (https=)
DE (1) DE69933581T2 (https=)
DK (1) DK1140149T3 (https=)
ES (1) ES2275359T3 (https=)
IL (2) IL143994A0 (https=)
PT (1) PT1140149E (https=)
SI (1) SI1140149T1 (https=)
WO (1) WO2000040260A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153288A0 (en) * 2000-06-07 2003-07-06 Applied Research Systems Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー 胚性細胞の定方向分化
DK1411918T3 (da) * 2001-07-31 2012-04-23 Genzyme Global S A R L Fremgangsmåder til at mobilisere progenitor/stamceller
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
CN103520735B (zh) * 2004-12-22 2015-11-25 Ambrx公司 包含非天然编码的氨基酸的人生长激素配方
BR112012015597A2 (pt) * 2009-12-21 2017-01-31 Ambrx Inc peptídeos de somatotropina suínos modificados e seus usos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
JPH08511263A (ja) * 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
IL111181A0 (en) * 1993-10-06 1994-12-29 Univ Florida Stem cell proliferation factor, its preparation, purification and uses
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
JPH11509845A (ja) * 1995-07-21 1999-08-31 アメリカ合衆国 造血多分化性細胞移植のための放射線または放射線類似作用化学療法の減少方法
JP2000503542A (ja) * 1996-01-16 2000-03-28 デピュイ オーソピーディック，インコーポレイテッド 造血及び非造血組織からの前駆細胞の分離及び ｉｎ ｖｉｖｏ 骨及び軟骨再生におけるそれらの使用
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
IL153288A0 (en) * 2000-06-07 2003-07-06 Applied Research Systems Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
CY1107603T1 (el) 2013-03-13
CA2354194A1 (en) 2000-07-13
WO2000040260A1 (en) 2000-07-13
EP1140149A1 (en) 2001-10-10
EP1140149B1 (en) 2006-10-11
IL143994A (en) 2009-06-15
DK1140149T3 (da) 2007-02-19
DE69933581D1 (de) 2006-11-23
AU2004203355B2 (en) 2007-05-17
ES2275359T3 (es) 2007-06-01
BR9916726A (pt) 2001-09-11
JP2002534393A (ja) 2002-10-15
AU2103900A (en) 2000-07-24
ATE342064T1 (de) 2006-11-15
DE69933581T2 (de) 2007-06-21
JP4808316B2 (ja) 2011-11-02
EP1779865A1 (en) 2007-05-02
PT1140149E (pt) 2007-01-31
SI1140149T1 (sl) 2007-02-28
EP1016413A1 (en) 2000-07-05
AU2004203355A1 (en) 2004-08-19
US20060029581A1 (en) 2006-02-09
AU772222B2 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
IL147990A0 (en) Multipotent adult stem cells and methods for isolation
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
WO2001021766A3 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
AU4094099A (en) Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
WO2003004605A3 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
IL188472A (en) Method for generating endoderm cells from human pluripotent stem cells
GB2393734B (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
WO2003059276A3 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
AU2003285172A8 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
SG147437A1 (en) Crystalline form of gamma-aminobutyric acid analog
WO2003018751A3 (en) Apparatus and method for electroporation of biological samples
WO2003027247A3 (en) Modulation of stem cells using zinc finger proteins
BRPI0413002A (pt) genes de ciclo de célula de planta e métodos de uso
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
GB9925964D0 (en) Hair transplantation
TNSN05166A1 (en) Isolating ingredients from biological material
ATE473273T1 (de) Angereicherte zellpopulationen des zentralen nervensystems
WO2004044127A3 (en) Stem cell populations
WO2000066731A3 (en) Recombinant laminin 5
WO2005037219A3 (en) Disinfecting teat care compositions
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
AU2002224383A1 (en) Method and marker for the isolation of human multipotent hematopoietic stem cells
WO2003062197A3 (en) Nek2 inhibitors